Compass Therapeutics Inc (CMPX)
1.60
+0.06
(+3.90%)
USD |
NASDAQ |
May 16, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics Price: 1.60 for May 16, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 16, 2024 | 1.56 | 1.61 | 1.56 | 1.60 | 301565.0 |
May 15, 2024 | 1.65 | 1.69 | 1.54 | 1.54 | 684177.0 |
May 14, 2024 | 1.52 | 1.635 | 1.52 | 1.615 | 371572.0 |
May 13, 2024 | 1.71 | 1.71 | 1.41 | 1.56 | 258143.0 |
May 10, 2024 | 1.59 | 1.64 | 1.49 | 1.60 | 254288.0 |
May 09, 2024 | 1.56 | 1.61 | 1.52 | 1.59 | 138523.0 |
May 08, 2024 | 1.66 | 1.68 | 1.57 | 1.58 | 114380.0 |
May 07, 2024 | 1.70 | 1.73 | 1.65 | 1.68 | 257690.0 |
May 06, 2024 | 1.70 | 1.75 | 1.675 | 1.70 | 289335.0 |
May 03, 2024 | 1.77 | 1.79 | 1.68 | 1.70 | 465125.0 |
May 02, 2024 | 1.67 | 1.69 | 1.62 | 1.65 | 475536.0 |
May 01, 2024 | 1.46 | 1.61 | 1.44 | 1.57 | 273114.0 |
Apr 30, 2024 | 1.45 | 1.47 | 1.41 | 1.44 | 102956.0 |
Apr 29, 2024 | 1.47 | 1.50 | 1.40 | 1.46 | 82457.00 |
Apr 26, 2024 | 1.51 | 1.51 | 1.40 | 1.45 | 65666.00 |
Apr 25, 2024 | 1.42 | 1.48 | 1.33 | 1.48 | 468630.0 |
Apr 24, 2024 | 1.56 | 1.59 | 1.44 | 1.48 | 147907.0 |
Apr 23, 2024 | 1.49 | 1.56 | 1.48 | 1.52 | 72067.00 |
Apr 22, 2024 | 1.51 | 1.54 | 1.44 | 1.49 | 106512.0 |
Apr 19, 2024 | 1.47 | 1.583 | 1.41 | 1.47 | 232975.0 |
Apr 18, 2024 | 1.60 | 1.79 | 1.48 | 1.49 | 237451.0 |
Apr 17, 2024 | 1.59 | 1.68 | 1.50 | 1.53 | 120088.0 |
Apr 16, 2024 | 1.58 | 1.64 | 1.50 | 1.57 | 718709.0 |
Apr 15, 2024 | 1.62 | 1.65 | 1.52 | 1.58 | 127996.0 |
Apr 12, 2024 | 1.60 | 1.75 | 1.50 | 1.62 | 596002.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.20
Minimum
Feb 05 2024
8.80
Maximum
Apr 16 2021
3.110
Average
2.97
Median
Dec 08 2021
Price Benchmarks
CEL-SCI Corp | 1.40 |
AIM ImmunoTech Inc | 0.39 |
IGC Pharma Inc | 0.5958 |
NovaBay Pharmaceuticals Inc | 0.12 |
Protalix BioTherapeutics Inc | 1.17 |
Price Related Metrics
Price to Book Value | 1.402 |
Earnings Yield | -21.88% |
Market Cap | 220.14M |